Thursday, December 18, 2014 9:38:32 PM
I would think the spirit of the "5% ownership rule" certainly encompasses beneficial ownership and ownership via attribution, and JJ can't spread his shares among related entities to relieve his disclosure requirement. And like Rick says, there is NO disclosure requirement for MDMN as long as it willfully remains a non-reporting OTC issue. That isn't going to change. Re-read the second sentence of this paragraph to be reminded why.
I believe the reason for the "error" is far more simple and less sinister, however. Our "accountant" is quite sloppy and regularly resorts to cutting and pasting. That's all, IMHO.
There are other errors (even mathematical) in the most recent financials no one has mentioned, but they really aren't material other than to demonstrate management continues to have no inclination to deliver professional quality data to stockholders.
Again, no news here... Sadly.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM